Financial statements Baumgart Pharmaceuticals
Balance sheet of Baumgart Pharmaceuticals
Company age:
Age:
13 y. 7 m. 18 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of BAUMGART PHARMACEUTICALS
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
|---|---|---|---|---|---|
| Total assets | 192 462,72 | 267 856,85 | 64 190,15 | 22 765,76 | 14 652,00 |
| A. Fixed assets | 22 091,66 | 13 784,04 | 0,00 | 0,00 | 0,00 |
| B. Current assets | 170 371,06 | 254 072,81 | 64 190,15 | 22 765,76 | 14 652,00 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 192 462,72 | 267 856,85 | 64 190,15 | 22 765,76 | 14 652,00 |
| A. Equity | -166 939,98 | -93 340,16 | -162 280,32 | -164 737,42 | -165 083,30 |
| B. Liabilities and provisions for liabilities | 359 402,70 | 361 197,01 | 226 470,47 | 187 503,18 | 179 735,30 |
| I. Long-term liabilities | 80 281,10 | 76 749,41 | 25 110,06 | 10 248,69 | 0,00 |
| II. Short-term liabilities | 279 121,60 | 284 447,60 | 201 360,41 | 177 254,49 | 179 735,30 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.